Thusday morning, Thermo Fisher Scientific, which has a laboratory in Center Valley and also an Allentown location, reported ...

By combining two fundamentally different microscopy techniques, researchers can now measure the optical properties of a ...

Thermo Fisher Scientific Inc.'s TMO fourth-quarter 2025 adjusted earnings per share (EPS) of $6.57 beat the Zacks Consensus ...

Thermo Fisher Scientific beat Q4 expectations with EPS of $6.57 on revenue of $12.21 billion and shared its outlook for 2026.

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2025.

TMO heads into Q4 earnings with Specialty Diagnostics growth, fresh FDA approvals and launches that could lift results on Jan ...

Discover how polymer upcycling through reactive extrusion and FTIR microscopy enables enhanced blend compatibilization for ...

Indian American researcher’s new AI-enhanced scanning method promises to boost quest for high-resolution mapping of the brain ...

TMO ramps up acquisitions and product launches to drive growth, but heavy debt and currency headwinds raise questions for long-term holders.

Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 Index ...

For pharma and biotech companies today, traditional reliance on multiple vendors to manage different aspects of drug development may compound challenging market dynamics, such as escalating ...

Thermo Fisher Scientific is breaking out the big bills to score a clinical research treat. With $8.875 billion in cash, the life science giant is adding Clario Holdings to its goodie bag, the company ...